Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, China Health Technology Group Holding Co's average EBITDA Per Share Growth Rate was 194.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 15.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of China Health Technology Group Holding Co was 36.20% per year. The lowest was -55.00% per year. And the median was 4.90% per year.
China Health Technology Group Holding Co (OTCPK:CHBOF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
China Health Technology Group Holding Co 3-Year EBITDA Growth Rate Related Terms
CHBOF vs SSD, UFPI, BCC: 3-Year EBITDA Growth Rate Comparison
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co 3-Year EBITDA Growth Rate vs Forest Products Industry
For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where China Health Technology Group Holding Co's 3-Year EBITDA Growth Rate falls into.
China Health Technology Group Holding Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 15.20% mean?
China Health Technology Group Holding Co (CHBOF) has a 3-Year EBITDA Growth Rate of 15.20% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for China Health Technology Group Holding Co and its competitors. This is 210% above median its historical median of 4.90. According to the industry distribution chart, China Health Technology Group Holding Co ranks #47 out of 228 companies in the Forest Products industry, placing it in the top 20.6%.
Is China Health Technology Group Holding Co's 3-Year EBITDA Growth Rate too high?
China Health Technology Group Holding Co's current 3-Year EBITDA Growth Rate of 15.20% is 210% above median its 10-year median of 4.90. Based on the distribution chart, China Health Technology Group Holding Co ranks #47 out of 228 companies in the Forest Products industry, which is in the top quartile — a strong position relative to peers. Overall, China Health Technology Group Holding Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's 3-Year EBITDA Growth Rate compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #47 out of 228 companies for 3-Year EBITDA Growth Rate. This places China Health Technology Group Holding Co in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Forest Products company?
A good 3-Year EBITDA Growth Rate depends on the Forest Products industry context. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for China Health Technology Group Holding Co and its competitors. China Health Technology Group Holding Co's current 3-Year EBITDA Growth Rate is 15.20%, which is 210% above median its own 10-year median of 4.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current 3-Year EBITDA Growth Rate of 15.20%. The stock's GF Value™ is $0.06, compared to a current price of $0.03 — trading 45.1% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 15.20%, which is 210% above median its 10-year median of 4.90. China Health Technology Group Holding Co's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current 3-Year EBITDA Growth Rate is 15.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 45.1% below its estimated GF Value™ of $0.06.
Key valuation signals for CHBOF:
3-Year EBITDA Growth Rate: 15.20% (210% above median its 10-year median of 4.90)
GF Value™: $0.06 vs. price of $0.03 (45.1% below fair value)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
28GF Score
Get the complete analysis for CHBOF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
